Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 August 2023 | Story EDZANI NEPHALELA | Photo EDZANI NEPHALELA
Mbulelo Aven Jafta and Dr Engela van Staden
Mbulelo Aven Jafta, Xhariep Municipality Corporate Services Director, and Dr Engela van Staden, Deputy Vice-Chancellor: Academic at the UFS, sign a memorandum of understanding to enrich various communities in the Xhariep Municipality areas through leadership training.

The University of the Free State (UFS) has signed a memorandum of understanding with the South African Local Government Association (SALGA) and the Xhariep Municipality that is aimed at positively impacting communities through strategic partnerships. The organisations plan for their collaboration to make a significant difference by training 35 of their employees via the UFS Business School – 15 will undertake the Foundation Skills Short Learning Programme, and 20 the Bachelor’s degree in Management Leadership.

This joint effort will equip these employees with essential skills and knowledge and empower them to carry out their responsibilities efficiently and effectively. Rooted in the UFS’s Vision 130, this initiative fosters positive change within the community by enhancing social justice and innovation.

Dr Engela van Staden, Deputy Vice-Chancellor: Academic at the UFS, emphasised the university's dedication to human resource development and empowering individuals. “We were very excited when we got this engagement with you, and I hope it will be fruitful for you, because that’s the intention. We are also reaching out to other municipalities because we are doing it for our country, and the sooner we do it, the better the services you will deliver to people.” 

Xhariep Municipality expressed gratitude for the collaboration, recognising its significance in empowering its employees. Mbulelo Aven Jafta, Corporate Services Director at the municipality, thanked the university for accepting the partnership. “As a municipality, we are interested in capacitating our employees to perform their duties optimally. It is through these partnerships that we reach our intended targets. This is the first two projects, and many more will be coming as our partnership progresses, and we intend to use this opportunity to the best of our abilities.”

Jafta said that such partnerships encourage a more interconnected and interdependent world. “As organisations work towards common goals, they create a ripple effect that can lead to a brighter and more promising future and play a vital role in shaping a positive and sustainable future.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept